Sarkana Pharma
Wilmington, US · Founded 2020 · Delaware corporation
Founders & leadership
CF
Caroline FortierNamed on SEC filing
LM
Luc MarengereNamed on SEC filing
MC
Mark CiprianoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2020
▶$1.6MraisedFeb 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.6MraisedFeb 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Caroline FortierExecutive Officer
- Luc MarengereDirector
- Mark CiprianoExecutive Officer
- Amount sold
- $1.6M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Sarkana Pharma raised?
- Sarkana Pharma has disclosed $1.6M raised across 1 round.
- Where is Sarkana Pharma headquartered?
- Sarkana Pharma is headquartered in Wilmington, US.